Related Experiment Video

Updated: Mar 14, 2026

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.3K

Pembrolizumab: Role of Modeling and Simulation in Bringing a Novel Immunotherapy to Patients With Melanoma

R de Greef1,2, J Elassaiss-Schaap1,3, M Chatterjee1

  • 1Merck & Co., Inc, Kenilworth, New Jersey, USA.

CPT: Pharmacometrics & Systems Pharmacology
|September 23, 2016
PubMed

Insights

Immunotherapy shows promise in cancer treatment. Novel therapies may be effective at lower doses than previously thought, requiring new approaches to drug dosing and combination trials.

Area of Science:

  • Oncology
  • Pharmacology
  • Clinical Trial Design

Background:

  • Immunotherapy has emerged as a significant advancement in cancer treatment.
  • Classical chemotherapy dosing paradigms may not be optimal for novel targeted therapies.

Discussion:

  • Maximum tolerated dose (MTD) is not always the most effective dose for novel targeted therapies.
  • Efficacy of targeted therapies can be robust at doses below MTD.

Key Insights:

  • Integrated safety and efficacy assessments are crucial for novel cancer therapies.
  • Dose selection for targeted therapies requires a departure from traditional MTD approaches.

Outlook:

  • New clinical trial designs are needed to optimize dosing for targeted therapies.
  • Identifying safe and effective combination treatments early is essential for advancing cancer care.

More Related Videos

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation05:33

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

2.4K
A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.7K

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.7K
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
652
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K